The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 11,301–11,400 of 31,469
Faulkner, L. D., Dowling, A. R., Stuart, R. C., Nillni, E. A., & Hill, J. W. (2015) · Endocrinology · doi:10.1210/en.2014-1788 · Cited by 31
Goh, G. B., Pagadala, M. R., Dasarathy, J., Ünalp–Arida, A., Pai, R. K., Yerian, L. M., Khiyami, A., Sourianarayanane, A., Sargent, R., Hawkins, C., et al. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3529-8 · Cited by 31
FABP4 plasma levels are increased in familial combined hyperlipidemia
Cabre, A., Lázaro, I., Cofán, M., Jarauta, E., Plana, N., García-Otín, A. L., Ascaso, J. F., Ferré, R., Civeira, F., Ros, E., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m900066 · Cited by 31
Association between insulin, leptin, adiponectin and blood pressure in youth
Lambert, M. A., O’Loughlin, J. L., DELVIN, E. E., Levy, E. H., Chioléro, A., & Paradis, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832935b6 · Cited by 31
Perugini, R. A., Li, Y., ROSENTHAL, L. S., Gallagher-Dorval, K. A., Kelly, J. J., & Czerniach, D. R. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.09.012 · Cited by 34
Seet, R. C. S., Lee, J. C., Lim, E. C. H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2124 · Cited by 31
Alkhouri, N., Alisi, A., Okwu, V., et al. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3614-z · Cited by 31
Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome
Öktenli, Ç., Özgürtaş, T., Dede, M., Sanısoğlu, Y., Yenen, M. C., Yeşilova, Z., Kenar, L., Kurt, Y. G., Başer, İ., Smith, J., et al. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701666571 · Cited by 31
Karakurt, F., Gümüş, İ. İ., Bavbek, N., et al. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802291824 · Cited by 31
Kurtz, T. A., Fineberg, N. S., Considine, R. V., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.004 · Cited by 31
Overexpression of TRB3 Gene in Adipose Tissue of Rats with High Fructose-induced Metabolic Syndrome
Bi, X., Tan, H., Xing, S., Wang, Z., Tang, M., Zhang, Y., & Zhang, W. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-049 · Cited by 31
Malin, S. K., Kashyap, S., Hammel, J. P., Miyazaki, Y., DeFronzo, R. A., & Kirwan, J. P. (2014) · Diabetes Care · doi:10.2337/dc13-3011 · Cited by 31
Birnbaum, Y., Nanhwan, M. K., Ling, S., Perez-Polo, J. R., Ye, Y., & Bajaj, M. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6546-5 · Cited by 31
Qureshi, K., Clements, R. H., Saeed, F., & Abrams, G. A. (2010) · Journal of Obesity · doi:10.1155/2010/741521 · Cited by 31
Faraj, M., Lavoie, M.-È., Messier, L., Bastard, J., & Prud’homme, D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.012 · Cited by 31
Yu, J., Yim, S. H., Yu, S. H., Lee, J., Kim, J. D., Seo, M. H., Jeon, W. S., Park, S., Park, C., Lee, W., et al. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.1.33 · Cited by 31
Liu, I.-M., Tzeng, T., & Liou, S. (2009) · Phytotherapy Research · doi:10.1002/ptr.2918 · Cited by 31
Saely, C. H., Risch, L., Hoefle, G., Rein, P., Muendlein, A., Marte, T., Aczél, S., Langer, P. H., & Drexel, H. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.029 · Cited by 31
Marrades, M. P., Martínez, J. A., & Moreno-Aliaga, M. J. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602500 · Cited by 31
Park, J. S., Cho, M. H., Nam, J. S., Ahn, C. W., Soo, B., Lee, E. J., Lim, S. K., Kim, K. R., & Lee, H. C. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0125-4 · Cited by 31
Druet, C., Ong, K. K., & Lévy‐Marchal, C. (2010) · Hormone Research in Paediatrics · doi:10.1159/000284359 · Cited by 31
Enli, Y., Fenkçi, S. M., Fenkçi, V., et al. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.829442 · Cited by 31
Rajaie, S., Azadbakht, L., Khazaei, M., Sherbafchi, M., & Esmaillzadeh, A. (2013) · Nutrition · doi:10.1016/j.nut.2013.06.011 · Cited by 31
Measurement of Salivary Resistin Level in Patients with Type 2 Diabetes
Yin, J., Gao, H., Yang, J., et al. (2012) · International Journal of Endocrinology · doi:10.1155/2012/359724 · Cited by 31
Soyman, Z., Noyan, V., Tulmaç, M., Yücel, A., Sağsöz, N., Bayrak, T., Bayrak, A., & Çakır, E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.011 · Cited by 32
Darendelıler, F., Poyrazoğlu, Ş., Sancaklı, Ö., Baş, F., Gökçay, G., Akı, S., & Eskiyurt, N. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03394.x · Cited by 31
Ghattas, M. H., & Abo–Elmatty, D. M. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1739 · Cited by 31
Alteration of postprandial glucose and insulin concentrations with meal frequency and composition
Kanaley, J. A., Heden, T. D., Liu, Y., & Fairchild, T. J. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514002128 · Cited by 31
Reactive oxygen species production is increased in the peripheral blood monocytes of obese patients
Degasperi, G. R., Denis, R., Morari, J., Solon, C., Geloneze, B., Stabe, C. F. C., Pareja, J. C., Vercesi, A. E., & Velloso, L. A. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.002 · Cited by 31
High-fat diets rich in soy or fish oil distinctly alter hypothalamic insulin signaling in rats
Pimentel, G. D., Dornellas, A. P. S., Neto, J. C. R., Lira, F. S., Cunha, C. A., Boldarine, V. T., Souza, G. I. H., Hirata, A. E., do Nascimento, C. M. O., Oyama, L. M., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.04.006 · Cited by 31
Ylönen, S. K., Salminen, I., Lyssenko, V., Virtanen, S. M., Groop, L., Aro, A., & Saloranta, C. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602882 · Cited by 28
Chiang, C., Lai, J., Hung, S.-H., Lee, L., Sheu, J., & Huang, K. (2013) · Obesity · doi:10.1002/oby.20000 · Cited by 31
The effect of comprehensive lifestyle intervention or metformin on obesity in young women☆
Lim, S. S., Norman, R. J., Clifton, P. M., & Noakes, M. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.006 · Cited by 31
Song, Y.-S., Fang, C.-H., So, B.-I., Park, J.-Y., Lee, Y., Shin, J., Jun, D. W., Kim, H., & Kim, K.-S. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/342648 · Cited by 31
Insulin resistance increases risk of carpal tunnel syndrome: a case‐control study
Plastino, M., Fava, A., Colica, C., Bartolo, M. D., Ermio, C., Cristiano, D., Ettore, M., Abenavoli, L., & Bosco, D. (2011) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2011.00344.x · Cited by 31
Multiple biomarkers and their relative contributions to identifying metabolic syndrome
Lee, J. G., Lee, S. Y., Kim, Y. J., Jin, H. K., Cho, B. M., Kim, Y. J., Jeong, D. W., Park, H. J., & Kim, J. E. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.07.006 · Cited by 31
Ramos, A., de Abreu, M., Vendramini, R. C., Brunetti, I. L., & Pepato, M. T. (2006) · Obesity Surgery · doi:10.1381/096089206778663706 · Cited by 31
Obesity, metabolic abnormality, and knee osteoarthritis: A cross-sectional study in Korean women
Lee, S., Kim, T. N., Kim, S.-H., Kim, Y., Lee, C., Moon, H., Koh, E., & Yoo, B. (2014) · Modern Rheumatology · doi:10.3109/14397595.2014.939393 · Cited by 32
Bulut, S., Bodur, E., Çolak, R., & Turnagöl, H. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.09.022 · Cited by 31
Bidens pilosaFormulation Improves Blood Homeostasis andβ-Cell Function in Men: A Pilot Study
Lai, B.-Y., Chen, T., Huang, S., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/832314 · Cited by 31
Kalaitzakis, E., Josefsson, A., Castedal, M., et al. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.777468 · Cited by 31
Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome
Berberoğlu, Z., Aktas, A., Fidan, Y., Yazıcı, A. C., & Aral, Y. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0560-8 · Cited by 33
Makihara, H., Shimada, T., Machida, E., Oota, M., Nagamine, R., Tsubata, M., Kinoshita, K., Takahashi, K., & Aburada, M. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0606-y · Cited by 32
Boronat, M., Saavedra, P., Pérez-Martín, N., López-Madrazo, M. J., Rodríguez-Pérez, C., & Novoa, F. J. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-81 · Cited by 31
Martin, R. M., Holly, J. M. P., Middleton, N., Smith, G. D., & Gunnell, D. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602616 · Cited by 31
Ragnarsson, Ó., Nyström, H. F., & Johannsson, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04174.x · Cited by 31
Belo, V. D. A., Luizon, M. R., Carneiro, P. C., et al. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2356-7 · Cited by 31
Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy.
Rasgon, N., Kenna, H. A., Wroolie, T., Williams, K., Demuth, B., & Silverman, D. (2014) · Psychiatry Research · doi:10.1016/j.pscychresns.2014.04.004 · Cited by 28
The Development of Hypertension and Hyperaldosteronism in a Rodent Model of Life-Long Obesity
Northcott, C. A., Fink, G. D., Garver, H. S., Haywood, J. R., Laimon-Thomson, E. L., McClain, J. L., Pires, P. W., Rainey, W. E., Rigsby, C. S., & Dorrance, A. M. (2012) · Endocrinology · doi:10.1210/en.2011-1176 · Cited by 30
Guillen, M. A., Mejía, F., Villena, J. E., Turin, C. G., Cárcamo, C., & Ticse, R. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0046-z · Cited by 31
Naka, K. Κ., Papathanassiou, K., Bechlioulis, A., Pappas, K. D., Kazakos, N., Kanioglou, C., Kostoula, A., Vezyraki, P., Makriyiannis, D., Tsatsoulis, A. A., et al. (2011) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111424515 · Cited by 31
Kim, J., Kim, S., Lee, W., Cheon, Y., Lee, S., Ju, A., Min, K., & Kim, D. J. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01921.x · Cited by 31
von Düring, M. E., Jenssen, T. G., Bollerslev, J., Åsberg, A., Godang, K., Eide, I. A., Dahle, D. O., & Hartmann, A. (2015) · Transplant International · doi:10.1111/tri.12606 · Cited by 31
Giribabu, N., Kilari, E. K., Rekha, S. S., Muniandy, S., & Salleh, N. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.9056 · Cited by 31
Insulin resistance possible risk factor for cognitive impairment in fibromialgic patients
Fava, A., Plastino, M., Cristiano, D., Spanò, A., Cristofaro, S., Opipari, C., Chillà, A., Casalinuovo, F., Colica, C., De Bartolo, M., et al. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9421-3 · Cited by 31
Sundsten, T., Östenson, C., & Bergsten, P. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.789 · Cited by 31
Holzapfel, C., Siegrist, M., Rank, M., Langhof, H., Grallert, H., Baumert, J. J., Irimie, C., Klopp, N., Wolfarth, B., Illig, T., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0588 · Cited by 31
Yadav, R., France, M. W., Aghamohammadzadeh, R., Liu, Y., Hama, S., Kwok, S., Schofield, J. D., Turkington, P. M., Syed, A. A., Malik, R. A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3939 · Cited by 31
Genetics of variation in HOMA-IR and cardiovascular risk factors in Mexican-Americans
Voruganti, V. S., López-Alvarenga, J. C., Nath, S. D., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0273-3 · Cited by 31
Sources of endogenous glucose production in the Goto–Kakizaki diabetic rat
Sena, C. M., Barosa, C., Nunes, E., Seiça, R. M. F., & Jones, J. G. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.03.002 · Cited by 31
Hua, N., Chen, Z., Phinikaridou, A., Pham, T. A., Qiao, Y., LaValley, M. P., Bigornia, S., Ruth, M. R., Apovian, C. M., Ruberg, F. L., et al. (2014) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-16-37 · Cited by 30
Can, M. F., Yağcı, G., Dağ, B., et al. (2008) · Nutrition · doi:10.1016/j.nut.2008.07.021 · Cited by 31
Mancini, A., Leone, E., Festa, R., Grande, G., Donna, V. D., Marinis, L. D., Pontecorvi, A., Tacchino, R. M., Littarru, G. P., Silvestrini, A., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2008.05.007 · Cited by 30
Park, Y., Kwon, H., Lim, S., Lee, J. H., Yoon, K., Son, H., Yim, H. W., & Lee, W.-C. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.4.511 · Cited by 31
Hirose, H., Takayama, M., Iwao, Y., & Kawabe, H. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.30700 · Cited by 31
de Santana, A. A., Santamarina, A. B., Souza, G., Mennitti, L. V., Okuda, M. H., Venâncio, D. P., Seelaender, M. C. L., do Nascimento, C. O., Ribeiro, E., Lira, F. S., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.03.001 · Cited by 31
Pacifico, L., Arca, M., Anania, C., Cantisani, V., Martino, M. D., & Chiesa, C. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.08.003 · Cited by 31
No evidence of mass dependency of specific organ metabolic rate in healthy humans
Later, W., Bosy‐Westphal, A., Hitze, B., Kossel, E., Glüer, C.-C., Heller, M., & Müller, M. J. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.1004 · Cited by 31
KCNQ1 gene polymorphisms are associated with lipid parameters in a Chinese Han population
Chen, Z., Quanzhong, Y., Ma, G., et al. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-35 · Cited by 31
Lee, H., Muniyappa, R., Xu, Y., Yue, L. Q., Linden, E. H., Chen, H., HANSEN, B. C., & Quon, M. J. (2011) · Endocrinology · doi:10.1210/en.2010-1164 · Cited by 31
EFFECT OF CHRONIC ASPIRIN ADMINISTRATION ON AN EXPERIMENTAL MODEL OF METABOLIC SYNDROME
Renna, N. F., Prieto, M. A. V., Lama, M. C., González, E. S., & Miatello, R. M. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05042.x · Cited by 31
den Beukel, C. V. D. B., Bos, M. V. D., Oyen, W. J. G., et al. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00630.x · Cited by 31
Takahashi, N., Anan, F., Nakagawa, M., Yufu, K., Shinohara, T., Tsubone, T., Goto, K., Masaki, T., Katsuragi, I., Tanaka, K., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2007.02.005 · Cited by 31
Lin, R.-T., Pai, H.-C., Lee, Y., Tzeng, C., Chang, C.-H., Hung, P., Chen, Y., Hsu, T., Tsai, C.-C., Lin, J., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/969824 · Cited by 30
Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes
Shim, W. S., Kim, S. K., Kim, H. J., Kang, E. S., Ahn, C. W., Lim, S. K., Lee, H. C., & Soo, B. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02249 · Cited by 31
Friedrichsen, M. H., Poulsen, P., Wojtaszewski, J. F. P., Hansen, P. R., Vaag, A. A., & Rasmussen, H. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056861 · Cited by 33
The incretin effect in critically ill patients: a case–control study
Nielsen, S. T., Janum, S., Krogh‐Madsen, R., Solomon, T. P. J., & Møller, K. (2015) · Critical Care · doi:10.1186/s13054-015-1118-z · Cited by 30
Mobasseri, M., Payahoo, L., Ostadrahimi, A., Bishak, Y. K., Jafarabadi, M. A., & Mahluji, S. (2014) · Pharmaceutical Sciences · Cited by 31
Zammit, A. R., Katz, M. J., Derby, C. A., Bitzer, M., & Lipton, R. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139369 · Cited by 31
Mossmann, M., Wainstein, M. V., Gonçalves, S. C., et al. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0085-5 · Cited by 31
Nguyen, Q. M., Srinivasan, S. R., Xu, J., Chen, W., & Berenson, G. S. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.14 · Cited by 31
Vasomotor symptoms and metabolic syndrome in Korean postmenopausal women
Ryu, K.-J., Park, H., Kwon, D. H., Yang, K., Kim, Y. J., Yi, K. W., Shin, J., Hur, J. Y., & Kim, T. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000461 · Cited by 31
Carraro, J. C. C., Mansego, M. L., Milagro, F. I., Chaves, L. O., Vidigal, F. D. C., Bressan, J., & Martínez, J. A. (2016) · Biomarkers · doi:10.3109/1354750x.2016.1171904 · Cited by 33
SAPMAZ, F. P., Uzman, M., Başyığıt, S., Özkan, S., Yavuz, B., Yeniova, A. Ö., Kefeli, A., Asiltürk, Z., & Nazlıgül, Y. (2016) · Medicine · doi:10.1097/md.0000000000003280 · Cited by 31
Kuźmicki, M., Telejko, B., Lipińska, D., Pliszka, J., Wilk, J., Wawrusiewicz‐Kurylonek, N., Zielińska, A., Sobota, A., Kretowski, A. J., Górska, M., et al. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0023 · Cited by 31
Jamaluddin, J. L., Huri, H. Z., & Vethakkan, S. R. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0010 · Cited by 31
Wannamethee, S. G., Welsh, P. I., LENNON, L. T., Papacosta, O., Whincup, P. H., & Sattar, N. A. (2016) · Diabetologia · doi:10.1007/s00125-016-4011-7 · Cited by 32
Kara, M., Doğru, T., Genç, H., Sertoğlu, E., Çelebi, G., Gürel, H., Kayadibi, H., Çiçek, A. F., Erçin, C. N., & Sönmez, A. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000405 · Cited by 31
Larsen, K. T., Huang, T., Ried‐Larsen, M., Andersen, L. B., Heidemann, M., & Møller, N. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157182 · Cited by 32
Aborehab, N. M., Bishbishy, M. H. E., & Waly, N. E. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1203-0 · Cited by 31
Sung, K., Chang, Y., Ryu, S., & Chung, H.-K. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0432-3 · Cited by 31
Renal function and carotid atherosclerosis in adults with no known kidney disease
Buscemi, S., Geraci, G., Massenti, F. M., Buscemi, C., Costa, F. D., D'Orio, C., Rosafio, G., Buscemi, C., Maniaci, V., & Parrinello, G. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.09.013 · Cited by 31
Association between global leukocyte DNA methylation and cardiovascular risk in postmenopausal women
Ramos, R. B., Fabris, V. C., Lecke, S. B., Maturana, M. A., & Spritzer, P. M. (2016) · BMC Medical Genetics · doi:10.1186/s12881-016-0335-x · Cited by 31
Elkind-Hirsch, K. E., Paterson, M. S., Seidemann, E. L., & Gutowski, H. C. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.023 · Cited by 34
Lallukka, S., Luukkonen, P. K., Zhou, Y., Isokuortti, E., Leivonen, M., Juuti, A., Hakkarainen, A., Orho‐Melander, M., Lundbom, N. M. I., Olkkonen, V. M., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-09-0716 · Cited by 32
Shim, Y. S., Kang, M. J., Oh, Y. J., Baek, J. W., Yang, S., & Hwang, I. T. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.38323 · Cited by 31
Liver and Metformin: Lessons of a fructose diet in mice
Karise, I., Ornellas, F., Barbosa‐da‐Silva, S., Matsuura, C., del Sol, M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2017) · Biochimie Open · doi:10.1016/j.biopen.2017.01.002 · Cited by 31
Kasuga, Y., Hata, K., Tajima, A., Ochiai, D., Saisho, Y., Matsumoto, T., Arata, N., Miyakoshi, K., & Tanaka, M. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0431 · Cited by 32
Norde, M. M., Oki, É., Carioca, A. A. F., Damasceno, N. R. T., Fisberg, R. M., Marchioni, D. M. L., & Rogero, M. M. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.02.009 · Cited by 32
Impact of end-stage renal disease on glucose metabolism—a matched cohort analysis
Guthoff, M., Wagner, R. J., Vosseler, D., Peter, A., Nadalin, S., Häring, H., Fritsche, A., & Heyne, N. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx018 · Cited by 31
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
